206 related articles for article (PubMed ID: 25894193)
1. Human leukocyte antigen G and renal allograft transplant.
Farid E; Al-Wedaie F; Tabbara K; El-Agroudy AE; Al-Ghareeb SM
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():371-6. PubMed ID: 25894193
[TBL] [Abstract][Full Text] [Related]
2. T-regulatory cells in chronic rejection versus stable grafts.
Al-Wedaie F; Farid E; Tabbara K; El-Agroudy AE; Al-Ghareeb SM
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():170-6. PubMed ID: 25894149
[TBL] [Abstract][Full Text] [Related]
3. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
[TBL] [Abstract][Full Text] [Related]
4. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of sHLA-G-mediated with better graft acceptance in early posttransplantation.
Jin HL; Li CR; Xiao L; Shi BY; Cai M; Li ZL; Wang S; Chen LP; Zhan SL; Li PC
Transplant Proc; 2012 Jun; 44(5):1259-61. PubMed ID: 22663996
[TBL] [Abstract][Full Text] [Related]
6. Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.
Okushi Y; Okino K; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
Clin Exp Nephrol; 2017 Oct; 21(5):932-940. PubMed ID: 28364323
[TBL] [Abstract][Full Text] [Related]
7. Expression of HLA-G transcripts in graft biopsy samples of renal transplant recipients.
Žilinská Z; Bandžuchová H; Chrastina M; Trebatický B; Breza J; Handzušová M; Kuba D; Tirpáková J; Pavlechová M; Dedinská I; Rychlý B; Poláková K
Transpl Immunol; 2015 Nov; 33(3):159-65. PubMed ID: 26455418
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
[TBL] [Abstract][Full Text] [Related]
9. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant.
Shooshtarizadeh T; Mohammadali A; Ossareh S; Ataipour Y
Exp Clin Transplant; 2013 Jun; 11(3):229-33. PubMed ID: 23477385
[TBL] [Abstract][Full Text] [Related]
10. Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study.
Zhao Z; Yang C; Tang Q; Zhao T; Jia Y; Ma Z; Rong R; Xu M; Zhu T
Transplant Proc; 2012 Dec; 44(10):2982-5. PubMed ID: 23195010
[TBL] [Abstract][Full Text] [Related]
11. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
12. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
[TBL] [Abstract][Full Text] [Related]
13. Donor-derived human leukocyte antigen class I proteins in the serum of heart transplant recipients.
DeVito-Haynes LD; Jankowska-Gan E; Heisey D; Jutte NH; Balk AH; Weimar W; Claas FH; Warner TF; Mentzer RM; Love RB; Burlingham WJ
J Heart Lung Transplant; 1996 Oct; 15(10):1012-26. PubMed ID: 8913919
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen-G 3' untranslated region polymorphisms are associated with better kidney allograft acceptance.
Cilião Alves DC; de Oliveira Crispim JC; Castelli EC; Mendes-Junior CT; Deghaide NH; Barros Silva GE; Costa RS; Saber LT; Moreau P; Donadi EA
Hum Immunol; 2012 Jan; 73(1):52-9. PubMed ID: 22044721
[TBL] [Abstract][Full Text] [Related]
15. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
[TBL] [Abstract][Full Text] [Related]
16. Assessment of different biomarkers provides valuable diagnostic standards in the evaluation of the risk of acute rejection.
Zheng J; Ding X; Tian X; Jin Z; Pan X; Yan H; Feng X; Hou J; Xiang H; Ren L; Tian P; Xue W
Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):730-6. PubMed ID: 22759804
[TBL] [Abstract][Full Text] [Related]
17. Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.
Peng ZG; Tian J
Clin Transpl; 2014; ():209-14. PubMed ID: 26281147
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pre transplant T-cell activation status by soluble CD 30 determination.
Abbas K; Muzaffar R; Zafar MN; Mubarak M; Naqvi SA; Rizvi SA
J Pak Med Assoc; 2009 Apr; 59(4):212-5. PubMed ID: 19402280
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of B cells in acute kidney transplant rejection.
Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
[TBL] [Abstract][Full Text] [Related]
20. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
